Antifungals Cut Risk of Invasive Infections in... - CLL Support

CLL Support

23,335 members40,042 posts

Antifungals Cut Risk of Invasive Infections in Neutropenic Patients

Cllcanada profile image
CllcanadaTop Poster CURE Hero
2 Replies

If you are Neutropenic, you may wish to discuss these new findings with your doctor.

Patients receiving therapy for haematological malignancies have a higher risk of invasive fungal infections (IFIs). Antifungal prophylaxis is an effective strategy against IFIs.

The study found that ...

Antifungal prophylaxis was more effective than no prophylaxis/placebo in reducing IFI risk.

Posaconazole was also found to be more effective than no prophylaxis/placebo in reducing all-cause mortality. The drug had the highest probability of being the most effective agent in reducing IFI risk and all-cause mortality.

The researchers say the results are consistent with the recommendations made in previous studies. In fact, the order of antifungal preference "matches that recommended in a recent study of the German Society for Haematology and Oncology."

Article Medscape ... free to join...

medscape.com/viewarticle/81...

Abstract

jac.oxfordjournals.org/cont...

~chris

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

Thanks Chris,

That's another addition to my reference folder for when treatment is needed.

Nice picture too. Is that a cornflower?

Neil

Cllcanada profile image
CllcanadaTop Poster CURE Hero

I have thought for years that opportunistic fungal infections are under studied in CLL, and probably under treated, especially in end stage.

Yup a cornflower in the Ottawa countryside...

Not what you're looking for?

You may also like...

Clinical Trials of Monoclonal antibodies AZD7442 against SARS=CoV-2 (COVID19) - majority of sites in UK and USA

There are two clinical trials of monoclonal antibodies that target covid19. AstraZeneca is...
Jm954 profile image
Administrator

Strategic Masking to Protect Patients from All Respiratory Viral Infections

This topic is often raised on this forum and this paper makes the case for continued masking in...
Jm954 profile image
Administrator

Breaking News! The AZD7442 PROVENT Phase III Prophylaxis Trial met its primary endpoint in preventing symptomatic COVID-19!

Clinical Trial Breaking News Today! CLL Society is delighted to share today's readout from the...
bkoffman profile image
CLL CURE Hero

Curbing Fluoroquinolone Antibiotics Tied to Britain's Drop in C.Diff

We've had previous warning posts about the worrying risk of severe side effects from...
AussieNeil profile image
Partner

Share your feelings and live longer

Sharing how you are feeling with others (and where better than on this site with people that know...
AussieNeil profile image
Partner